Yukihiro Kitanaga

发表

Discovery of a novel Igβ and FcγRIIB cross-linking antibody, ASP2713, and its potential application in the treatment of systemic lupus erythematosus.

T. Sumida, Yoshiya Tanaka, Y. Kondo, 2021, International immunopharmacology.

Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors

Yoshiya Tanaka, S. Nakayamada, K. Yamagata, 2018, Annals of the rheumatic diseases.

In vitro pharmacological effects of peficitinib on lymphocyte activation: a potential treatment for systemic sclerosis with JAK inhibitors

Yoshiya Tanaka, S. Nakayamada, E. Imamura, 2019, Rheumatology.

Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis.

Yoshiya Tanaka, S. Nakayamada, S. Iwata, 2021, Rheumatology.

Preclinical Characterization of ASP2713, a Novel Igβ and FcγRIIB Cross-linking Antibody, for Prediction of Human Pharmacokinetics and Clinically Effective Dose.

T. Sumida, N. Yamamoto, Y. Kondo, 2022, Journal of pharmaceutical sciences.

Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System

Yoshiya Tanaka, S. Nakayamada, K. Yamagata, 2018, Front. Immunol..

Kdm5a promotes B cell activation in systemic lupus erythematosus via downregulation of A20 by histone modification.

Yoshiya Tanaka, S. Iwata, Jie Fan, 2021, Pathology, research and practice.

Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus.

Yoshiya Tanaka, S. Nakayamada, S. Iwata, 2019, Clinical immunology.

Sequential Regulation of Gibberellin, Brassinosteroid, and Jasmonic Acid Biosynthesis Occurs in Rice Coleoptiles to Control the Transcript Levels of Anti-Microbial Thionin Genes

J. Yazaki, I. Yamaguchi, N. Kishimoto, 2006, Bioscience, biotechnology, and biochemistry.